Orhan IE - Search Results

1

An overview on natural cholinesterase inhibitors--a multi-targeted drug class--and their mass production.

Orhan IE, Orhan G, Gurkas E. Orhan IE, et al. Among authors: orhan g. Mini Rev Med Chem. 2011 Sep;11(10):836-42. doi: 10.2174/138955711796575434. Mini Rev Med Chem. 2011. PMID: 21762104 Review.

2

Contemporary anticholinesterase pharmaceuticals of natural origin and their synthetic analogues for the treatment of Alzheimer's disease.

Orhan G, Orhan I, Subutay-Oztekin N, Ak F, Sener B. Orhan G, et al. Recent Pat CNS Drug Discov. 2009 Jan;4(1):43-51. doi: 10.2174/157488909787002582. Recent Pat CNS Drug Discov. 2009. PMID: 19149713 Review.

3

Assessment of enzyme inhibitory and antioxidant activities of lignans from Taxus baccata L.

Kucukboyaci N, Orhan I, Sener B, Nawaz SA, Choudhary MI. Kucukboyaci N, et al. Z Naturforsch C J Biosci. 2010 Mar-Apr;65(3-4):187-94. doi: 10.1515/znc-2010-3-404. Z Naturforsch C J Biosci. 2010. PMID: 20469636 Free article.

4

Evaluation of cholinesterase inhibitory and antioxidant activities of wild and cultivated samples of sage (Salvia fruticosa) by activity-guided fractionation.

Senol FS, Orhan IE, Erdem SA, Kartal M, Sener B, Kan Y, Celep F, Kahraman A, Dogan M. Senol FS, et al. Among authors: orhan ie. J Med Food. 2011 Nov;14(11):1476-83. doi: 10.1089/jmf.2010.0158. Epub 2011 Jun 11. J Med Food. 2011. PMID: 21663475

5

Insights into cholinesterase inhibitory and antioxidant activities of five Juniperus species.

Orhan N, Orhan IE, Ergun F. Orhan N, et al. Among authors: orhan ie. Food Chem Toxicol. 2011 Sep;49(9):2305-12. doi: 10.1016/j.fct.2011.06.031. Epub 2011 Jun 25. Food Chem Toxicol. 2011. PMID: 21708212

6

Current concepts on selected plant secondary metabolites with promising inhibitory effects against enzymes linked to Alzheimer's disease.

Orhan IE. Orhan IE. Curr Med Chem. 2012;19(14):2252-61. doi: 10.2174/092986712800229032. Curr Med Chem. 2012. PMID: 22414107 Review.

7

Flavonoid derivatives as potent tyrosinase inhibitors - a survey of recent findings between 2008-2013.

Orhan IE, Khan MT. Orhan IE, et al. Curr Top Med Chem. 2014;14(12):1486-93. doi: 10.2174/1568026614666140523120741. Curr Top Med Chem. 2014. PMID: 24853561 Review.

8

In silico approach to inhibition of tyrosinase by ascorbic acid using molecular docking simulations.

Senol FS, Khan MT, Orhan G, Gurkas E, Orhan IE, Oztekin NS, Ak F. Senol FS, et al. Among authors: orhan ie, orhan g. Curr Top Med Chem. 2014;14(12):1469-72. doi: 10.2174/1568026614666140610121253. Curr Top Med Chem. 2014. PMID: 24917394

9

Implications of some selected flavonoids towards Alzheimer's disease with the emphasis on cholinesterase inhibition and their bioproduction by metabolic engineering.

Orhan IE. Orhan IE. Curr Pharm Biotechnol. 2014;15(4):352-61. doi: 10.2174/1389201015666140813123204. Curr Pharm Biotechnol. 2014. PMID: 25312618 Review.

10

Chemical and molecular aspects on interactions of galanthamine and its derivatives with cholinesterases.

Gulcan HO, Orhan IE, Sener B. Gulcan HO, et al. Among authors: orhan ie. Curr Pharm Biotechnol. 2015;16(3):252-8. doi: 10.2174/1389201015666141202105105. Curr Pharm Biotechnol. 2015. PMID: 25483718 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters